Eledon Pharmaceuticals (ELDN) EPS (Basic) Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.35% |
| Dec 31, 2025 | -16.81% |
| Sep 30, 2025 | 47.97% |
| Jun 30, 2025 | 45.65% |
| Mar 31, 2025 | 60.69% |
| Dec 31, 2024 | 32.60% |
| Sep 30, 2024 | 17.73% |
| Jun 30, 2024 | -24.81% |
| Mar 31, 2024 | -133.53% |
| Dec 31, 2023 | 16.02% |
| Sep 30, 2023 | 2.26% |
| Jun 30, 2023 | -51.79% |
| Mar 31, 2023 | -15.81% |
| Dec 31, 2022 | -141.30% |
| Sep 30, 2022 | -11.17% |
| Jun 30, 2022 | 13.21% |
| Mar 31, 2022 | -3.18% |
| Dec 31, 2021 | -28.69% |
| Sep 30, 2021 | 31.42% |
| Jun 30, 2021 | 25.98% |
| Mar 31, 2021 | -2.25% |
| Dec 31, 2020 | 33.40% |
| Sep 30, 2020 | -59.73% |
| Jun 30, 2020 | -46.94% |
| Mar 31, 2020 | -70.58% |
| Dec 31, 2019 | -82.57% |
| Sep 30, 2019 | -8.15% |
| Jun 30, 2019 | 50.42% |
| Mar 31, 2019 | 44.40% |
| Dec 31, 2018 | 46.55% |
| Sep 30, 2018 | 44.17% |